 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
17 News |  |
- APVO210 / Medexus
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis (clinicaltrials.gov) - May 19, 2021
P1, N=85, Terminated, Sponsor: Aptevo Therapeutics
N=144 --> 85 | Trial completion date: Sep 2020 --> Jun 2020 | Active, not recruiting --> Terminated | Trial primary completion date: Sep 2020 --> Jun 2020; Business decision
- | APVO210 / Medexus
Enrollment closed: Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis (clinicaltrials.gov) - Oct 11, 2019
P1, N=144, Active, not recruiting, Sponsor: Aptevo Therapeutics
N=144 --> 85 | Trial completion date: Sep 2020 --> Jun 2020 | Active, not recruiting --> Terminated | Trial primary completion date: Sep 2020 --> Jun 2020; Business decision Recruiting --> Active, not recruiting
- ||| APVO210 / Medexus
Enrollment open: Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis (clinicaltrials.gov) - Mar 28, 2019
P1, N=144, Recruiting, Sponsor: Aptevo Therapeutics
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||| APVO210 / Medexus
New P1 trial: Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis (clinicaltrials.gov) - Dec 7, 2018
P1, N=144, Not yet recruiting, Sponsor: Aptevo Therapeutics